Sign in

Combating Facial Volume Loss With Cosmeceuticals

Jennifer Linder, MD May 2014 issue of Skin Inc. magazine
Combating Facial Volume Loss With Cosmeceuticals

Excerpt Only This is a shortened version or summary of the article you requested. To view the complete article, please log in or create an account. Registration is Free!

The loss of facial volume is a key contributor to an aged facial appearance. Although some of the visible loss of facial volume is due to reduced facial fat and the resorption of bones, you may be able to help clients potentially avoid resorting to a face lift, which simply stretches and removes excess tissue, by implementing topical cosmeceuticals that work to protect existing volume, and replace epidermal and dermal matrix volume that has already been lost. Although minimally invasive injectables are the gold standard once adipose tissue and bone mass have been lost, there are many proven ingredients and product categories that can be added to a client’s daily regimen to help preserve, maintain and increase the facial volume of the skin—and your clients’ youthful appearance.

The physiology of facial volume loss

The primary cause of visible facial aging of the skin is matrix degradation. The extracellular matrix (ECM) is a complex framework of biomolecules that support and protect dermal cells. The ECM is made up of structural proteins (collagen and elastin), adhesive proteins (laminins and fibronectin), glycosaminoglycans (GAGs) and proteoglycans. These components are all vitally important for a full, youthful appearance that is free of laxity, wrinkling and poor surface texture. The breakdown of these all-important structures is a result of both intrinsic aging that happens due to time and genetics, and extrinsic aging, which is largely avoidable.

The offending extrinsic factors

Although ECM-breakdown occurs naturally with the passage of time, it is accelerated by external factors, primarily UV exposure. The oxidative stress instigated by UV rays increases matrix metalloproteinase (MMP) production—the enzymes that breakdown the ECM. These enzymes are increased with as little as 0.1 minimal erythema dose (MED), which is one-tenth of the UV exposure it takes for skin to become red. This demonstrates the critical nature of the daily, year-round use of broad-spectrum sun protection; you don’t need to tan to begin the cascade of facial volume loss. (Editor’s note: See the article “Sunscreens: What You (and Your Clients) Must Know” in the May 2014 issue.)

Excerpt Only This is a shortened version or summary of the article you requested. To view the complete article, please log in or create an account. Registration is Free!

Related Content

 

Skip

Welcome to the new SkinInc.com!

Delivering the best information on the spa, skin care and wellness industry is our passion, and we’ve worked hard to design a powerful new website that incorporates cutting-edge technology to bring you:

  • Mobile-friendly Design
  • Integrated Sample Request
  • Refreshed Look and Feel
  • Dynamic Content
  • Free Registration

Mobile-friendly Design

Providing a unified experience from mobile to desktop, responsive design allows you to access Skin Inc. content from any device, whether you’re in the treatment room, at home or on the go!

Integrated Sample Request

Visit Featured Product pages to quickly and easily identify new suppliers and request product samples and information.

Dynamic Content

Articles are now linked with relevant products so you can find the products and treatments you need to provide the best results for your clients.

Free Registration

Create your user account to gain unlimited access to Skin Inc.’s unparalleled content.

Enjoy the New SkinInc.com!

Thank you for joining the Skin Inc. community of passionate skin care professionals. We look forward to providing you the best information to enhance your career!